Seymour JF - Search Results

1

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.

Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating M, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O'Brien S, Robak T, Seymour JF, Kipps TJ. Hallek M, et al. Among authors: seymour jf. Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14. Blood. 2018. PMID: 29540348 Free article.

2

Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56).

Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Seymour JF, et al. Leukemia. 1994 May;8(5):823-6. Leukemia. 1994. PMID: 7514247

3

Parathyroid hormone related protein in hypercalcaemia in CLL.

Seymour JF, Keating MJ. Seymour JF, et al. Br J Haematol. 1995 Mar;89(3):685-6. doi: 10.1111/j.1365-2141.1995.tb08394.x. Br J Haematol. 1995. PMID: 7734384 No abstract available.

4

Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.

Seymour JF, Estey EH, Keating MJ, Kurzrock R. Seymour JF, et al. Leukemia. 1995 May;9(5):929-32. Leukemia. 1995. PMID: 7769859

5

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia.

Seymour JF, Kurzrock R, Freireich EJ, Estey EH. Seymour JF, et al. Blood. 1994 May 15;83(10):2906-11. Blood. 1994. PMID: 7910051 Free article.

6

Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review.

Seymour JF, Khouri IF, Champlin RE, Keating MJ. Seymour JF, et al. Am J Clin Oncol. 1994 Aug;17(4):360-8. doi: 10.1097/00000421-199408000-00016. Am J Clin Oncol. 1994. PMID: 8048400 No abstract available.

7

Survival of young patients with chronic lymphocytic leukemia failing fludarabine therapy: a basis for the use of myeloablative therapies.

Seymour JF, Robertson LE, O'Brien S, Lerner S, Keating MJ. Seymour JF, et al. Leuk Lymphoma. 1995 Aug;18(5-6):493-6. doi: 10.3109/10428199509059650. Leuk Lymphoma. 1995. PMID: 8528058 Clinical Trial.

8

Case/control study of the role of splenectomy in chronic lymphocytic leukemia.

Seymour JF, Cusack JD, Lerner SA, Pollock RE, Keating MJ. Seymour JF, et al. J Clin Oncol. 1997 Jan;15(1):52-60. doi: 10.1200/JCO.1997.15.1.52. J Clin Oncol. 1997. PMID: 8996124

9

Role of splenectomy in chronic lymphocytic leukemia.

Cusack JC Jr, Seymour JF, Lerner S, Keating MJ, Pollock RE. Cusack JC Jr, et al. Among authors: seymour jf. J Am Coll Surg. 1997 Sep;185(3):237-43. doi: 10.1016/s1072-7515(97)00057-4. J Am Coll Surg. 1997. PMID: 9291400

10

Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II study.

Giles FJ, O'Brien SM, Santini V, Gandhi V, Plunkett W, Seymour JF, Robertson LE, Kantarjian HM, Keating MJ. Giles FJ, et al. Among authors: seymour jf. Leuk Lymphoma. 1999 Dec;36(1-2):57-65. doi: 10.3109/10428199909145949. Leuk Lymphoma. 1999. PMID: 10613450 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

560 results

Search Page